Clinical Outcomes Following Transcutaneous Auricular Neurostimulation to Improve Relapse Prevention: A Long-term Follow-up Study
Public ClinicalTrials.gov record NCT05591703. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a prospective, observational, longitudinal study to assess clinical outcomes in the 12-months following participants' exit from protocol SBM-OWP-03, Delivering Transcutaneous Auricular Neurostimulation to Improve Relapse Prevention in Opioid Use Disorder (RESTORE; ClinicalTrials.gov Identifier: NCT05053503). Clinical outcome scores will be collected at study exit from protocol SBM-OWP-03, 1 month, 3 months, 6 months, 9 months, and 12 months after study exit from protocol SBM-OWP-03.
Study identification
- NCT ID
- NCT05591703
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 32 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 20, 2022
- Primary completion
- Jan 30, 2025
- Completion
- Jan 30, 2025
- Last update posted
- Apr 8, 2025
2022 – 2025
United States locations
- U.S. sites
- 3
- U.S. states
- 2
- U.S. cities
- 3
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Betty Ford Foundation | Rancho Mirage | California | 92270 | — |
| Hazelden Betty Ford Foundation | Center City | Minnesota | 55012 | — |
| Hazelden Betty Ford Foundation | Plymouth | Minnesota | 55441 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Opioid Use Disorder trials
Other public records listing Opioid Use Disorder. Sorted by last update posted; newest first. Not a recommendation.
- NCT07795840: The ConCERN Intervention for Loved Ones of Those With Opioid Use Disorder Not yet recruiting
- NCT07787039: Supporting Treatment for Opioids and Recovery Capital (STORC) - R61 Phase Not yet recruiting
- NCT07780097: TRTME: Improving Outpatient Initiation of Medication for Opioid Use Disorder Following Hospitalization Recruiting
- NCT07778394: Personalized Addiction Treatment eHancement Recruiting
- NCT07610746: Cerebral Physiology of NOWS Recruiting
- NCT07770555: Deep Transcranial Magnetic Stimulation for Tobacco Cessation in Adults With Opioid Use Disorder Not yet recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05591703, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 8, 2025 · Synced Sep 7, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05591703 live on ClinicalTrials.gov.